ISurTec
Generated 5/3/2026
Executive Summary
ISurTec (Innovative Surface Technologies, Inc.) is a San Diego-based medtech company that develops and commercializes advanced surface modification technologies, primarily lubricious hydrophilic coatings for medical devices, as well as specialized coatings for in vitro diagnostics and cell culture. Founded in 2007, the company operates as a B2B technology provider and contract developer, serving medical device and life science markets. Its coatings enhance device performance by reducing friction and improving biocompatibility. With a focus on contract development and long-standing market presence, ISurTec is positioned as a reliable partner in the medical device supply chain. While the company is private and has limited public disclosures, its niche expertise in surface coatings addresses growing demand for minimally invasive devices and advanced diagnostics, offering steady but incremental growth opportunities.
Upcoming Catalysts (preview)
- Q4 2026New coating supply agreement with a top-10 medical device manufacturer40% success
- TBDExpansion of coating platform into cell culture market through partnership50% success
- Q2 2027Launch of next-generation hydrophilic coating for neurovascular interventions35% success
- · Pipeline Analysis
- · Competitive Landscape
- · Catalyst Calendar (full 12-month)
- · Bull Case
- · Bear Case
- · Counterfactual Scenarios
- · Valuation Notes
- · SEC Filing Highlights
- · Insider Activity
- · Literature Watch
- · Patent Landscape
- · Mechanism Cluster Map
- · Audio Briefing (5 min)